← Open Payments lookup

GLENDA WILBURN: Open Payments

NPI 1861650574 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,581 in 78 payments from 15 companies in 2025. Trend: 2023 $1,528 · 2024 $1,272 · 2025 $1,581

Food & beverage: $1,581
CompanyPaymentsAmount
ABBVIE INC.21$333
Bayer Healthcare Pharmaceuticals Inc.11$199
AstraZeneca Pharmaceuticals LP2$192
Sumitomo Pharma America, Inc.6$151
Axsome Therapeutics, Inc.8$147
PFIZER INC.7$131
Lilly USA, LLC6$116
Astellas Pharma US Inc5$89
GlaxoSmithKline, LLC.3$60
Vanda Pharmaceuticals Inc.3$51

Products named: Kerendia, BREZTRI, GEMTESA, Auvelity, QULIPTA, MOUNJARO, ELIQUIS, VRAYLAR.

Industry payments across TX — which companies pay providers there.